Ardelyx Down ~8% As Co. Earlier Announced Tenapanor Reduces Pain Caused by IBS-C Through Inhibition of TRPV-1 Signaling; Mentioned In PR That They Will Move Forward To Submit NDA To FDA In Second Half Of 2018